Prognostic impact of CD168 expression in gastric cancer.
Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T, Uchikado Y, Setoyama T, Arima H, Yoshiaki K, Kijima Y, Kitazono M, Natsugoe S.
Ishigami S, et al.
BMC Cancer. 2011 Mar 24;11:106. doi: 10.1186/1471-2407-11-106.
BMC Cancer. 2011.
PMID: 21435222
Free PMC article.